Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02462070. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to evaluate the safety and efficacy of a topical lotion.
Study identification
- NCT ID
- NCT02462070
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 203 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2015 (Actual)
- Primary completion
- Nov 8, 2016 (Actual)
- Completion
- Dec 1, 2016 (Actual)
- Last update posted
- Aug 20, 2020
2015 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 3 | Mobile | Alabama | 36601 | — |
| Valeant Site 9 | Beverly Hills | California | 90210 | — |
| Valeant Site 12 | Encino | California | 91316 | — |
| Valeant Site 10 | San Diego | California | 92093 | — |
| Valeant Site 1 | Santa Rosa | California | 95403 | — |
| Valeant Site 16 | Denver | Colorado | 80123 | — |
| Valeant Site 2 | Tampa | Florida | 33601 | — |
| Valeant Site 7 | South Bend | Indiana | 46601 | — |
| Valeant Site 8 | Louisville | Kentucky | 40202 | — |
| Valeant Site 13 | Clinton Township | Michigan | 48036 | — |
| Valeant Site 14 | Rochester | New York | 14603 | — |
| Valeant Site 6 | Nashville | Tennessee | 37115 | — |
| Valeant Site 5 | Austin | Texas | 73344 | — |
| Valeant Site 4 | Houston | Texas | 77001 | — |
| Valeant Site 11 | Norfolk | Virginia | 23501 | — |
| Valeant Site 15 | Spokane | Washington | 99201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02462070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2020 · Synced Nov 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.